Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4

por Huang, Lu, Ding, Wei, Wang, Ming-Qiang, Wang, Zheng-Gen, Chen, Hong-Hui, Chen, Wen, Yang, Qiong, Lu, Ting-Na, Yang, Qing, He, Ji-Man
Publicado 2019